Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Yongzheng Pharmaceutical is a comprehensive pharmaceutical enterprise based in Foshan, China, specializing in the research, development, and manufacturing of a wide range of medicinal products. The company is particularly well-known for its pediatric healthcare portfolio, which includes popular treatments for respiratory and digestive ailments such as Xiao'er Kechuanling Granules. Its product line encompasses both modern chemical drugs, including antibiotics and analgesics, and traditional Chinese medicine (TCM) preparations. Operating with multiple GMP-certified production lines, the company maintains a significant presence in the domestic Chinese market through both over-the-counter (OTC) and prescription drug channels. Yongzheng Pharmaceutical focuses on high-quality manufacturing standards to ensure the safety and efficacy of its diverse therapeutic offerings. The company continues to expand its reach within the Chinese healthcare sector by leveraging its established brand and manufacturing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Yongzheng Pharmaceutical.